IMJUDO tremelimumab 25 mg/ 1.25 mL concentrated injection vial

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 5cb3064f3fdc7057
Product Name: IMJUDO tremelimumab 25 mg/ 1.25 mL concentrated injection vial
Artg Id: 387299
Artg Name: IMJUDO tremelimumab 25 mg/ 1.25 mL concentrated injection vial
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2023-06-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

5cb3064f3fdc7057

Type

Standard